Status:
TERMINATED
Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions:
Breast Cancer
Lymphedema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed research is designed to establish lymphedema incidence rates for a varied population of breast cancer patients. Patients with breast preservation, mastectomy, sentinel lymph node biopsy, ...
Detailed Description
Background: Lymphedema has varied definitions, all based on limb volume changes. None incorporates limb volume changes, symptoms, and functional deficits. We will determine the incidence of lymphedema...
Eligibility Criteria
Inclusion
- Age of 18 years or older, biopsy proven breast cancer with no known metastatic cancer, surgical management of breast cancer with node evaluation to be completed at Johns Hopkins Hospital, ability to speak and read English, willing and able to continue follow-up at Johns Hopkins Avon foundation Breast Center -
Exclusion
- Known psychiatric illness, unwillingness to be followed for two years, functional arm deficits, prior radiation therapy to the breast or axilla, any prior diagnosis of cancer except basal cell cancer
- \-
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2007
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00282529
Start Date
January 1 2006
End Date
November 1 2007
Last Update
January 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Avon Breasts Center, Johns Hopkins Medical Institutions
Baltimore, Maryland, United States, 21287